[SCHEDULE 13G] Bioceres Crop Solutions Corp. SEC Filing
BAF Latam Credit Fund B.V. reports beneficial ownership of 3,461,430 ordinary shares of Bioceres Crop Solutions Corp. (BIOX), representing 5.52% of the class based on the issuer's reported outstanding share count of 62,712,602. The filing states BAF holds sole voting power and sole dispositive power over the disclosed shares.
The statement was submitted on Schedule 13G and includes an Item 10 certification that the securities were not acquired to change or influence control of the issuer, indicating the filer describes the position as passive under the Schedule 13G framework.
BAF Latam Credit Fund B.V. comunica la titolarit脿 effettiva di 3.461.430 azioni ordinarie di Bioceres Crop Solutions Corp. (BIOX), pari al 5,52% della categoria sul totale delle azioni in circolazione dichiarate dall'emittente di 62.712.602. La comunicazione indica che BAF detiene la piena potest脿 di voto e la piena potest脿 dispositiva sulle azioni segnalate.
La dichiarazione 猫 stata presentata con uno Schedule 13G e contiene una certificazione dell'Item 10 che specifica che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente, segnalando quindi che il dichiarante considera la posizione come passiva nell'ambito dello Schedule 13G.
BAF Latam Credit Fund B.V. informa la titularidad beneficiaria de 3.461.430 acciones ordinarias de Bioceres Crop Solutions Corp. (BIOX), que representan el 5,52% de la clase seg煤n el n煤mero de acciones en circulaci贸n declarado por el emisor de 62.712.602. El documento se帽ala que BAF posee el poder de voto exclusivo y el poder dispositivo exclusivo sobre las acciones comunicadas.
La declaraci贸n se present贸 mediante un Schedule 13G e incluye una certificaci贸n del Item 10 que afirma que los valores no fueron adquiridos para cambiar o influir en el control del emisor, lo que indica que el declarante describe la posici贸n como pasiva en el marco del Schedule 13G.
BAF Latam Credit Fund B.V.電� Bioceres Crop Solutions Corp.(BIOX)鞚� 3,461,430 氤错喌欤�鞐� 雽�頃� 鞁れ唽鞙犽ゼ 鞁犼碃頄堨溂氅�, 鞚措姅 氚滍枆靷皜 氤搓碃頃� 氚滍枆欤检嫕靾� 62,712,602毳� 旮办鞙茧 頃措嫻 膦呺鞚� 5.52%鞐� 頃措嫻頃╇媹雼�. 鞁犼碃靹滌棎電� BAF臧� 瓿奠嫓霅� 欤检嫕鞐� 雽�頃� 雼弲 鞚橁舶甓�瓿� 雼弲 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堧嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
鞚� 氤搓碃靹滊姅 Schedule 13G搿� 鞝滌稖霅橃棃鞙茧┌ Item 10 鞚胳鞚� 韽暔頃橁碃 鞛堨柎 頃措嫻 歃濌秾鞚� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 氚濏瀳瓿�, 霐半澕靹� 鞝滌稖鞛愱皜 Schedule 13G 觳搓硠靸� 頃措嫻 歆�攵勳潉 靾橂彊鞝�(韺嫓敫�)鞙茧 靹る獏頃橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�.
BAF Latam Credit Fund B.V. d茅clare la propri茅t茅 b茅n茅ficiaire de 3 461 430 actions ordinaires de Bioceres Crop Solutions Corp. (BIOX), repr茅sentant 5,52 % de la cat茅gorie sur la base du nombre d'actions en circulation d茅clar茅 par l'茅metteur de 62 712 602. Le d茅p么t pr茅cise que BAF d茅tient le pouvoir de vote exclusif et le pouvoir discr茅tionnaire exclusif sur les actions divulgu茅es.
La d茅claration a 茅t茅 d茅pos茅e sous forme de Schedule 13G et inclut une certification Item 10 indiquant que les titres n'ont pas 茅t茅 acquis afin de modifier ou d'influencer le contr么le de l'茅metteur, ce qui signifie que le d茅clarant d茅crit la position comme passive au titre du cadre Schedule 13G.
BAF Latam Credit Fund B.V. meldet wirtschaftliches Eigentum an 3.461.430 Stammaktien von Bioceres Crop Solutions Corp. (BIOX), was 5,52% der Klasse entspricht, basierend auf der vom Emittenten angegebenen ausstehenden Aktienzahl von 62.712.602. Die Einreichung gibt an, dass BAF 眉ber die offengelegten Aktien die alleinige Stimmrechtsbefugnis und die alleinige Verf眉gungsmacht besitzt.
Die Erkl盲rung wurde als Schedule 13G eingereicht und enth盲lt eine Item-10-Zertifizierung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen, was darauf hinweist, dass der Einreicher die Position im Rahmen von Schedule 13G als passiv beschreibt.
- BAF disclosed beneficial ownership of 3,461,430 shares, representing 5.52% of BIOX's outstanding class.
- Sole voting and sole dispositive power over the disclosed shares is explicitly reported.
- Filed on Schedule 13G with Item 10 certification stating the position was not acquired to change control, clarifying passive intent.
- None.
Insights
TL;DR: BAF reports a passive, >5% stake in BIOX with full voting and dispositive powers over 3.46M shares.
From a capital markets perspective this Schedule 13G discloses a material minority holding: 3,461,430 shares (5.52%). The filing explicitly records sole voting and dispositive authority for those shares, which means BAF can exercise voting rights on that block but has certified the position as passive under Schedule 13G. The disclosure improves transparency around shareholder composition but does not, by itself, signal an intent to change control.
TL;DR: Ownership crosses the 5% reporting threshold and is documented as passive with a formal certification against control-seeking.
The filing identifies BAF Latam Credit Fund B.V. as a non-U.S. entity organized in the Netherlands holding sole voting and dispositive power over the disclosed shares. The use of Schedule 13G and the Item 10 certification are procedurally consistent with a passive investor disclosure. This provides clarity for governance registers about a concentrated, but non-controlling, shareholder position.
BAF Latam Credit Fund B.V. comunica la titolarit脿 effettiva di 3.461.430 azioni ordinarie di Bioceres Crop Solutions Corp. (BIOX), pari al 5,52% della categoria sul totale delle azioni in circolazione dichiarate dall'emittente di 62.712.602. La comunicazione indica che BAF detiene la piena potest脿 di voto e la piena potest脿 dispositiva sulle azioni segnalate.
La dichiarazione 猫 stata presentata con uno Schedule 13G e contiene una certificazione dell'Item 10 che specifica che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente, segnalando quindi che il dichiarante considera la posizione come passiva nell'ambito dello Schedule 13G.
BAF Latam Credit Fund B.V. informa la titularidad beneficiaria de 3.461.430 acciones ordinarias de Bioceres Crop Solutions Corp. (BIOX), que representan el 5,52% de la clase seg煤n el n煤mero de acciones en circulaci贸n declarado por el emisor de 62.712.602. El documento se帽ala que BAF posee el poder de voto exclusivo y el poder dispositivo exclusivo sobre las acciones comunicadas.
La declaraci贸n se present贸 mediante un Schedule 13G e incluye una certificaci贸n del Item 10 que afirma que los valores no fueron adquiridos para cambiar o influir en el control del emisor, lo que indica que el declarante describe la posici贸n como pasiva en el marco del Schedule 13G.
BAF Latam Credit Fund B.V.電� Bioceres Crop Solutions Corp.(BIOX)鞚� 3,461,430 氤错喌欤�鞐� 雽�頃� 鞁れ唽鞙犽ゼ 鞁犼碃頄堨溂氅�, 鞚措姅 氚滍枆靷皜 氤搓碃頃� 氚滍枆欤检嫕靾� 62,712,602毳� 旮办鞙茧 頃措嫻 膦呺鞚� 5.52%鞐� 頃措嫻頃╇媹雼�. 鞁犼碃靹滌棎電� BAF臧� 瓿奠嫓霅� 欤检嫕鞐� 雽�頃� 雼弲 鞚橁舶甓�瓿� 雼弲 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堧嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
鞚� 氤搓碃靹滊姅 Schedule 13G搿� 鞝滌稖霅橃棃鞙茧┌ Item 10 鞚胳鞚� 韽暔頃橁碃 鞛堨柎 頃措嫻 歃濌秾鞚� 氚滍枆靷潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 氚濏瀳瓿�, 霐半澕靹� 鞝滌稖鞛愱皜 Schedule 13G 觳搓硠靸� 頃措嫻 歆�攵勳潉 靾橂彊鞝�(韺嫓敫�)鞙茧 靹る獏頃橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�.
BAF Latam Credit Fund B.V. d茅clare la propri茅t茅 b茅n茅ficiaire de 3 461 430 actions ordinaires de Bioceres Crop Solutions Corp. (BIOX), repr茅sentant 5,52 % de la cat茅gorie sur la base du nombre d'actions en circulation d茅clar茅 par l'茅metteur de 62 712 602. Le d茅p么t pr茅cise que BAF d茅tient le pouvoir de vote exclusif et le pouvoir discr茅tionnaire exclusif sur les actions divulgu茅es.
La d茅claration a 茅t茅 d茅pos茅e sous forme de Schedule 13G et inclut une certification Item 10 indiquant que les titres n'ont pas 茅t茅 acquis afin de modifier ou d'influencer le contr么le de l'茅metteur, ce qui signifie que le d茅clarant d茅crit la position comme passive au titre du cadre Schedule 13G.
BAF Latam Credit Fund B.V. meldet wirtschaftliches Eigentum an 3.461.430 Stammaktien von Bioceres Crop Solutions Corp. (BIOX), was 5,52% der Klasse entspricht, basierend auf der vom Emittenten angegebenen ausstehenden Aktienzahl von 62.712.602. Die Einreichung gibt an, dass BAF 眉ber die offengelegten Aktien die alleinige Stimmrechtsbefugnis und die alleinige Verf眉gungsmacht besitzt.
Die Erkl盲rung wurde als Schedule 13G eingereicht und enth盲lt eine Item-10-Zertifizierung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen, was darauf hinweist, dass der Einreicher die Position im Rahmen von Schedule 13G als passiv beschreibt.
FAQ
How many BIOX shares does BAF Latam Credit Fund B.V. own?
What percentage of BIOX does that holding represent?
Does BAF have voting or dispositive power over these shares?
Was the stake reported as passive or active?
Where is BAF Latam Credit Fund B.V. organized?
Who signed the filing on behalf of BAF?
